Literature DB >> 33446720

Spatial memory deficiency early in 6xTg Alzheimer's disease mouse model.

Shinwoo Kang1,2, Jinho Kim2,3, Keun-A Chang4,5,6.   

Abstract

Alzheimer's disease (AD) is mainly characterized by the deposition of extracellular amyloid plaques and intracellular accumulation of neurofibrillary tangles (NFTs). While the recent 5xFAD AD mouse model exhibits many AD-related phenotypes and a relatively early and aggressive amyloid β production, it does not show NFTs. Here, we developed and evaluated a novel AD mouse model (6xTg-AD, 6xTg) by crossbreeding 5xFAD mice with mice expressing mutant (P301L) tau protein (MAPT). Through behavioral and histopathological tests, we analyzed cognitive changes and neuropathology in 6xTg mice compared to their respective parental strains according to age. Spatial memory deficits occurred in 6xTg mice at 2 months of age, earlier than they occurred in 5xFAD mice. Histopathological data revealed aggressive Aβ42 and p-tau accumulation in 6xTg mice. Microglial activation occurred in the cortex and hippocampus of 6xTg mice beginning at 2 months. In 6xTg model mice, the synaptic loss was observed in the cortex from 4 months of age and in the hippocampus from 6 months of age, and neuronal loss appeared in the cortex from 4 months of age and in the hippocampus 6 months of age, earlier than it is observed in the 5xFAD and JNPL3 models. These results showed that each pathological symptom appeared much faster than in their parental animal models. In conclusion, these novel 6xTg-AD mice might be an advanced animal model for studying AD, representing a promising approach to developing effective therapy.

Entities:  

Year:  2021        PMID: 33446720      PMCID: PMC7809274          DOI: 10.1038/s41598-020-79344-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  37 in total

Review 1.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

3.  Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice.

Authors:  Céline Héraud; Doris Goufak; Kunie Ando; Karelle Leroy; Valérie Suain; Zehra Yilmaz; Robert De Decker; Michèle Authelet; Vincent Laporte; Jean-Noël Octave; Jean-Pierre Brion
Journal:  Neurobiol Dis       Date:  2013-09-27       Impact factor: 5.996

4.  Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.

Authors:  Anika Saul; Frederik Sprenger; Thomas A Bayer; Oliver Wirths
Journal:  Neurobiol Aging       Date:  2013-06-05       Impact factor: 4.673

5.  Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.

Authors:  Elena M Ribé; Mar Pérez; Berta Puig; Ignasi Gich; Filip Lim; Mar Cuadrado; Teresa Sesma; Silvia Catena; Belén Sánchez; María Nieto; Pilar Gómez-Ramos; M Asunción Morán; Felipe Cabodevilla; Lluis Samaranch; Lourdes Ortiz; Alberto Pérez; Isidro Ferrer; Jesús Avila; Teresa Gómez-Isla
Journal:  Neurobiol Dis       Date:  2005-08-24       Impact factor: 5.996

6.  Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density.

Authors:  Eric Falke; Jonathan Nissanov; Thomas W Mitchell; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

7.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

Authors:  Salvatore Oddo; Antonella Caccamo; Masashi Kitazawa; Bertrand P Tseng; Frank M LaFerla
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

8.  Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.

Authors:  Tristan Bolmont; Florence Clavaguera; Melanie Meyer-Luehmann; Martin C Herzig; Rebecca Radde; Matthias Staufenbiel; Jada Lewis; Mike Hutton; Markus Tolnay; Mathias Jucker
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

Review 9.  Inflammation as a central mechanism in Alzheimer's disease.

Authors:  Jefferson W Kinney; Shane M Bemiller; Andrew S Murtishaw; Amanda M Leisgang; Arnold M Salazar; Bruce T Lamb
Journal:  Alzheimers Dement (N Y)       Date:  2018-09-06

10.  Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model.

Authors:  Shinwoo Kang; Sungji Ha; Hyunjun Park; Eunjoo Nam; Won Hyuk Suh; Yoo-Hun Suh; Keun-A Chang
Journal:  Front Behav Neurosci       Date:  2018-11-13       Impact factor: 3.558

View more
  5 in total

1.  Neuropathological and behavioral features of an APP/PS1/MAPT (6xTg) transgenic model of Alzheimer's disease.

Authors:  Sung Hyun Tag; Baeksun Kim; Jinhee Bae; Keun-A Chang; Heh-In Im
Journal:  Mol Brain       Date:  2022-06-08       Impact factor: 4.399

2.  Resilient Hippocampal Gamma Rhythmogenesis and Parvalbumin-Expressing Interneuron Function Before and After Plaque Burden in 5xFAD Alzheimer's Disease Model.

Authors:  Connie A Mackenzie-Gray Scott; Kenneth A Pelkey; Adam P Caccavano; Daniel Abebe; Mandy Lai; Khayla N Black; Nicolette D Brown; Andrew J Trevelyan; Chris J McBain
Journal:  Front Synaptic Neurosci       Date:  2022-05-11

3.  MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer's Disease Model Mice.

Authors:  ShinWoo Kang; Jinho Kim; Sang-Yoon Lee; Nobuyuki Okamura; Keun-A Chang
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

4.  Idebenone Regulates Aβ and LPS-Induced Neurogliosis and Cognitive Function Through Inhibition of NLRP3 Inflammasome/IL-1β Axis Activation.

Authors:  Hyun-Ju Lee; Jin-Hee Park; Hyang-Sook Hoe
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

5.  Characterization of a Mouse Model of Alzheimer's Disease Expressing Aβ4-42 and Human Mutant Tau.

Authors:  Silvia Zampar; Oliver Wirths
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.